In-vitro activity of quinupristin/dalfopristin compared with other widely used antibiotics against strains isolated from patients with endocarditis

Journal of Antimicrobial Chemotherapy

Volumn 39, Issue SUPPL. A, 1997, Pages 75-80

  Mouton, J W ^a   Endtz, H P ^a   Den Hollander, J G ^a   Van den Braak, N ^a   Verbrugh, H A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFUROXIME; CLARITHROMYCIN; CLINDAMYCIN; DALFOPRISTIN; ERYTHROMYCIN; FLUCLOXACILLIN; GENTAMICIN; MINOCYCLINE; PENICILLIN G; QUINUPRISTIN; RIFAMPICIN; STREPTOGRAMIN DERIVATIVE; TEICOPLANIN; VANCOMYCIN;

ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL ENDOCARDITIS; COAGULASE NEGATIVE STAPHYLOCOCCUS; MINIMUM INHIBITORY CONCENTRATION; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS BOVIS; STREPTOCOCCUS GORDONII; STREPTOCOCCUS MITIS;

EID: 0030917097     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/39.suppl_1.75     Document Type: Article

References (21)

1. Fass, R. (1991). In vitro activity of RP 59500, a semisynthetic injectable pristinamycin, against staphylococci, streptococci and enterococci. Antimicrobial Agents and Chemotherapy 35, 553-9.
2. Brumfltt, W., Hamilton-Miller, J. M. T. & Shah, S. (1992). In-vitro activity of RP 59500, a new semi-synthetic streptogramin antibiotic, against Gram-positive bacteria. Journal of Antimicrobial Chemotherapy 30, Suppl. A, 29-38.
3. Verbist, L. & Verhaegen, J. (1992). Comparative in-vitro activity of RP 59500. Journal of Antimicrobial Chemotherapy 30, Suppl. A, 39-44.
4. Vasquez, D. (1967). Mechanism of action. In The Streptogramin Family of Antibiotics, Vol. 1 (Gottlieb, D. & Shaw, D., Eds), pp. 387-403. Springer Verlag, NY.
5. Aumercier, M., Bouhallab, S., Capmau, M.-L. & Le Goffic, F. (1992). RP 59500: a new proposed mechanism for its bacterial activity. Journal of Antimicrobial Chemotherapy 30, Suppl. A, 9-14.
6. Pechere, J. C. (1992). In-vitro activity of RP 59500, a semisynthetic streptogramin, against staphylococci and streptococci. Journal of Antimicrobial Chemotherapy 30 Suppl. A, 15-8.
7. van der Meer, J. T. M., van Vianen, W., Hu, E., van Leeuwen, W., Valkenburg, H. A., Thompson, J. & Michel, M. F. (1991). Distribution, antibiotic susceptibility and tolerance of bacterial isolates in culture-positive cases of endocarditis in the Netherlands. European Journal of Clinical Microbiology and Infectious Diseases 10, 728-34.
8. Facklam, R. R. & Carey, R. B. (1985). Streptococci and aerococci. In Manual of Clinical Microbiology (Lennette, E. H., Balows, A., Hausler, W. J. & Shadomy, H. J., Eds), pp. 54-175. American Society for Microbiology, Washington, DC.
9. National Committee for Clinical Laboratory Standards. (1990). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, 2nd edn; Approved Standard M7-A2. NCCLS, Villanova, PA.
10. Sahm, D. F. & Washington, J. A. (1991). Antibacterial susceptibility tests: dilution methods. In Manual of Clinical Microbiology (Balows, A., Hausler, W. J., Hermann, K. L., Isenberg, H. D. & Shadomy, H. J., Eds.), pp. 1105-16. American Society for Microbiology, Washington, DC.
11. SAS Institute Inc. (1990). SAS User's Guide. SAS Institute, Inc., Cary, NC.
12. Weisblum, B. (1985). Inducible resistance to macrolides, Lincosamides and streptogramin type B antibiotics: the resistance phenotype, its biological diversity and structural elements that regulate expression - a review. Journal of Antimicrobial Chemotherapy 16, Suppl. A, 63-90.
13. Etienne, S. D., Maontay, G., Le Liboux, A., Frydman, A. & Garaud, J. J. (1992). A phase I, double-blind, placebo controlled study of the tolerance and pharmacokinetic behaviour of RP 59500. Journal of Antimicrobial Chemotherapy 30, Suppl. A, 123-31.
14. Neu, H. O., Chin, N. & Gu, J. (1992). The in vitro activity of new streptogramins, RP 59500, RP 57669, and RP 54476, alone and in combinations. Journal of Antimicrobial Chemotherapy 30, Suppl. A, 83-94.
15. Cremieux, A. C., Maziere, B., Vallois, J. M., Ottaviani, M., Azancot, A., Raffoul, H. et al. (1989). Evaluation of antibiotic diffusion into cardiac vegetations by quantitative autoradlography. Journal of Infectious Diseases 159, 938-44.
16. Chambers, H. F. (1992). Studies of RP 59500 in vitro and in a rabbit model of aortic valve endocarditis caused by methicillin-resistant Staphylococcus aureus. Journal of Antimicrobial Chemotherapy 30, Suppl. A, 117-20.
17. Soussy, C. J., Acar, J. F., Cluzel, R., Courvalin, P., Duval, J., Fleurette, J. et al. (1992). A collaborative study of the in-vitro sensitivity to RP 59500 of bacteria isolated in seven hospitals in France. Journal of Antimicrobial Chemotherapy 30, Suppl. A, 53-8.
18. Hoban, D. J., Weshnoweski, B., Palatnick, L., Zhanel, L. & Davidson, R. L. (1992). In-vitro activity of streptogramin RP 59500 against staphylococci, including bacterial kinetic studies. Journal of Antimicrobial Chemotherapy 30, Suppl. A, 59-65.
19. Duval, J. (1985). Evolution and epidemiology of MLS resistance. Journal of Antimicrobial Chemotherapy 16, Suppl. A, 137-49.
20. Le Goffic, F., Capmeau, M.-L., Bonnet, D., Cerceau, C., Soussy, C., Dublanchet, A. et al. (1977). Plasmid-mediated pristinamycin resistance. PAC IIA a new enzyme which modifies pristinamycin IIA. Journal of Antibiotics 30, 665-9.
21. Leclerc, R. & Courvalin, P. (1991). Intrinsic and unusual resistance to macrolide, lincosamide, and streptogramin antibiotics in bacteria. Antimicrobial Agents and Chemotherapy 35, 1273-6.